c‐Abl Inhibitors as Disease‐Modifying Therapies for Parkinson's Disease: Gaps and Opportunities
Year: 2022
Type: editorial
Source: Movement Disorders
DOI: 10.1002/mds.28907
Authors: Kalpana Merchant, James Sullivan
Institutions: Northwestern University, Vanqua Bio (United States)
Language: English
Subfield: Clinical Neurology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4205170682
